The estimated Net Worth of Rene Sindlev is at least $173 Thousand dollars as of 18 May 2022. Mr. Sindlev owns over 253,493 units of Enochian Biosciences Inc stock worth over $89,945 and over the last 7 years he sold ENOB stock worth over $0. In addition, he makes $82,740 as Independent Chairman of the Board at Enochian Biosciences Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Mr. Sindlev ENOB stock SEC Form 4 insiders trading
Rene has made over 10 trades of the Enochian Biosciences Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he bought 253,493 units of ENOB stock worth $2,027,944 on 18 May 2022.
The largest trade he's ever made was buying 253,493 units of Enochian Biosciences Inc stock on 18 May 2022 worth over $2,027,944. On average, Rene trades about 22,772 units every 66 days since 2017. As of 18 May 2022 he still owns at least 128,493 units of Enochian Biosciences Inc stock.
You can see the complete history of Mr. Sindlev stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Rene Sindlev biography
Rene Sindlev serves as Independent Chairman of the Board of the Company. Mr. Sindlev has been successfully self-employed since 1985 from the age of 23. He has been an investor and entrepreneur since 1997 through his holding companies including RS Group ApS, RS Arving ApS, RS Family ApS, RS Newton ApS & RS Bio ApS. In January of 2014, Mr. Sindlev established Dr. Smood ApS in Denmark, and Dr. Smood Group, Inc. in the United States, a chain of all USDA Certified Organic health restaurants, and since 2014 he has served as its chairman. Mr. Sindlev has previously founded, owned and sold more than 28 companies in the Jewelry, Aviation, Charter and Real Estate Business, such as World of Watches A/S, Pandora A/S, RS Aviation ApS, Gråbrødrestræde ApS among others. In 2002, Mr. Sindlev co-founded Pandora A/S and served as President & Board Member, and as an advisor to the board before and after its IPO on Nasdaq Copenhagen in 2010. Mr. Sindlev co-founded Enochian Biosciences Inc. in February 2018 from being an early Biotech investor in DanDrit Biotech, Inc.
What is the salary of Rene Sindlev?
As the Independent Chairman of the Board of Enochian Biosciences Inc, the total compensation of Rene Sindlev at Enochian Biosciences Inc is $82,740. There are 8 executives at Enochian Biosciences Inc getting paid more, with Mark Dybul having the highest compensation of $1,964,450.
How old is Rene Sindlev?
Rene Sindlev is 59, he's been the Independent Chairman of the Board of Enochian Biosciences Inc since 2017. There are 1 older and 8 younger executives at Enochian Biosciences Inc. The oldest executive at Enochian Biosciences Inc is Carol Brosgart, 69, who is the Independent Director.
What's Rene Sindlev's mailing address?
Rene's mailing address filed with the SEC is 5 CORNICHE DU PARADIS, TERRESTRE, CANNES, I0, 06400.
Insiders trading at Enochian Biosciences Inc
Over the last 7 years, insiders at Enochian Biosciences Inc have traded over $2,106,789 worth of Enochian Biosciences Inc stock and bought 552,919 units worth $3,888,612 . The most active insiders traders include Gregg H Alton, Rene Sindlev, and Serhat Gumrukcu. On average, Enochian Biosciences Inc executives and independent directors trade stock every 91 days with the average trade being worth of $35,881. The most recent stock trade was executed by Serhat Gumrukcu on 18 May 2022, trading 253,493 units of ENOB stock currently worth $2,027,944.
What does Enochian Biosciences Inc do?
enochian biosciences (formerly dandrit biotech usa inc.) a biopharmaceutical company, focuses on the development and commercialization of novel therapies aimed to change the course of immunotherapy treatments for hiv/aids and cancer. the company’s lead candidate eno-1001 (pre-ind) is a potentially sterilizing cure for hiv/aids. eno-2001 is an hiv vaccine in preclinical stage, and its additional compounds eno-4001 (phase three asset), eno-4002, eno-5001, and eno-3001 are in discovery stages for prevention relapse in colon cancer patients. enochian biosciences is headquartered in los angeles, california.
What does Enochian Biosciences Inc's logo look like?
Complete history of Mr. Sindlev stock trades at Enochian Biosciences Inc
Enochian Biosciences Inc executives and stock owners
Enochian Biosciences Inc executives and other stock owners filed with the SEC include:
-
Mark Dybul,
Executive Vice Chairman of the Board, Principal Executive Officer -
Luisa Puche,
Chief Financial Officer -
Dr. Mark R. Dybul M.D.,
Chief Exec. Officer & Director -
Luisa Puche,
Chief Financial Officer -
Evelyn D'An,
Independent Director -
James Sapirstein,
Independent Director -
Carl Sandler,
Independent Director -
Henrik Gronfeldt-Sorensen,
Director -
Rene Sindlev,
Independent Chairman of the Board -
Gregg Alton,
Independent Director -
Carol Brosgart,
Independent Director -
Dr. François Binette M.Sc., Ph.D.,
Exec. VP for R&D -
Greg Duczynski Ph.D.,
Sr. VP for Clinical Operations -
Dr. Serhat Gümrükcü,
Co-Founder & Inventor -
Tung Nguyen,
Head of Molecular Biology -
Dr. Wenshi Wang,
Sr. VP of Operations -
Dr. Serhat Gümrükcü,
Co-Founder & Inventor -
Francois Binette,
Executive VP for R&D -
Jayne Mc Nicol,
Director -
Eric Jean Marie Leire,,
-
Carl Forest Sandler,
-
Serhat Gumrukcu,
10% owner -
Anderson Wittekind William,
-
Science Llc Weird,